
NASDAQHealthcareMedical - Diagnostics & Research
最新データ
$518
+$4.86 · +0.95%
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
前日終値
$518
+$4.86 · +0.95%
日中の時刻はETです。市場データは遅延する場合があります。
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
日中レンジ
現在 $518
52週レンジ
現在 $518
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
64
割安
センチメント
68
強気
リスク
43
やや高いリスク
モメンタム
42
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
日中レンジ
現在 $518
52週レンジ
現在 $518
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 43.04億 USD | 38.98億 USD | 36.61億 USD | 33.67億 USD | 32.15億 USD |
| 売上原価 | 16.44億 USD | 15.19億 USD | 14.71億 USD | 13.63億 USD | 13.26億 USD |
| 粗利益 | 26.6億 USD | 23.79億 USD | 21.9億 USD | 20.04億 USD | 18.89億 USD |
| 研究開発 | 2.51億 USD | 2.2億 USD | 1.91億 USD | 2.55億 USD | 1.61億 USD |
| 販売・一般管理 | 10.48億 USD | 10.31億 USD | 9.02億 USD | 8.51億 USD | 7.96億 USD |
| 営業費用 | 13億 USD | 12.51億 USD | 10.93億 USD | 11.06億 USD | 9.57億 USD |
| 受取利息 | 242.3万 USD | 1269.9万 USD | 562.9万 USD | 106.5万 USD | 43.4万 USD |
| 支払利息 | 3826.5万 USD | 3120.5万 USD | 4158.1万 USD | 3985.8万 USD | 2980.8万 USD |
| 減価償却費と償却費 | 1.45億 USD | 1.3億 USD | 1.15億 USD | 1.12億 USD | 1.05億 USD |
| 営業利益 | 13.6億 USD | 11.28億 USD | 10.97億 USD | 8.99億 USD | 9.32億 USD |
| 純利益 | 10.59億 USD | 8.88億 USD | 8.45億 USD | 6.79億 USD | 7.45億 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$665
上昇余地(28.38%)| 種別 | 発効日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
株式分割 | 2015年6月16日 | 2:1 | — | — |
株式分割 | 2007年11月27日 | 2:1 | — | — |
株式分割 | 1995年6月6日 | 2:1 | — | — |
株式分割 | 1993年10月4日 | 2:1 | — | — |
発効済み 2015年6月16日
2:1
発効済み 2007年11月27日
2:1
発効済み 1995年6月6日
2:1
発効済み 1993年10月4日
2:1
この株式へのエクスポージャーを報告している上場投資信託です。
State Street SPDR S&P 500 ETF1557.T784.53億0.06%129.35兆 JPY0.09%¥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI13.95億0.06%2.3兆 USD0.03%$381.94+0.63%
Vanguard S&P 500 ETFVOO11.66億0.07%1.8兆 USD0.03%$715.59+0.61%
Vanguard Morningstar Mid-Cap ETFVO9.5億0.42%2264億 USD0.03%$81.14+0.92%
Invesco QQQ Trust, Series 1QQQ8.51億0.17%5060.67億 USD0.18%$751.27+0.49%
iShares Core S&P 500 ETFIVV5.38億0.06%8964.4億 USD0.03%$781.97+0.60%
Vanguard Morningstar Growth ETFVUG5.2億0.14%3846億 USD0.03%$91.97+0.72%
State Street SPDR S&P 500 ETFSPY4.96億0.06%8172億 USD0.09%$778.57+0.60%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Mid-Cap ETFVO
Invesco QQQ Trust, Series 1QQQ
iShares Core S&P 500 ETFIVV
Vanguard Morningstar Growth ETFVUG
State Street SPDR S&P 500 ETFSPYAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。